22 Biopharma Stocks With Breakout Potential in 2012

Description:

According to Adam Feuerstein, "Drug approval decisions garner big headlines, but savvy and successful biotech investors know that making smart trading decisions ahead of important clinical trial results is the ticket to banking serious coin." Read more here.

>>Also: 6 Stocks to Play if the Market Tanks

>>Also: 3 Hot Stocks for a Sideways Market

Most Viewed Portfolios

View All

Articles

5 Rocket Stocks for Gluttonous Turkey Day Gains

11.24.14 | 07:56 AM

BALTIMORE ( Stockpickr) -- This Thanksgiving, have your turkey and mashed potatoes with a side of stock gains. It may sound surprising, but statist...

Time to Sell These 5 'Toxic' Stocks

11.21.14 | 11:27 AM

BALTIMORE ( Stockpickr) -- Which stocks should I buy? It's the eternal question that most investors spend most of their time wondering. But is it t...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter